Evidence map›Paper›PMID 37515742›Full record

ArticleAIDS and behavior2024

Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas: A Multi-site Cross-Sectional Study, 2018-2020.

Umedjon Ibragimov, Melvin D Livingston, April M Young, Judith Feinberg, P Todd Korthuis, Wajiha Z Akhtar, Wiley D Jenkins, Heidi M Crane, Ryan P Westergaard, Robin Nance and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Umedjon IbragimovBSHES Department of Emory University School of Public Health, Atlanta, GA, USA. umed.ibragimov@emory.edu.ORCID http://orcid.org/0000-0001-7111-2139
Melvin D LivingstonBSHES Department of Emory University School of Public Health, Atlanta, GA, USA.
April M YoungDepartment of Epidemiology and Environmental Health, College of Public Health, University of Kentucky, Lexington, KY, USA.
Judith FeinbergDepartments of Behavioral Medicine & Psychiatry and Medicine/Infectious Diseases, School of Medicine, West Virginia University, Morgantown, WV, USA.
P Todd KorthuisSection of Addiction Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
Wajiha Z AkhtarPopulation Health Institute, University of Wisconsin-Madison, Madison, WI, USA.
Wiley D JenkinsDepartment of Population Science and Policy, Southern Illinois University School of Medicine, Carbondale, IL, USA.
Heidi M CraneDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
Ryan P WestergaardDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Robin NanceDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
William C MillerDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
John BresettDepartment of Population Science and Policy, Southern Illinois University School of Medicine, Carbondale, IL, USA.
Dalia KhouryRTI International, Research Triangle, NC, USA.
Christopher B HurtInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Vivian F GoDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kerry NolteDepartment of Nursing, College of Health and Human Services, University of New Hampshire, Durham, NH, USA.
Hannah L F CooperBSHES Department of Emory University School of Public Health, Atlanta, GA, USA.

Funding

Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)UH3DA044829 · NIDA · UNIVERSITY OF CHICAGO · PI JENKINS, WILEY, PHO, MAI TUYET · 2019 to 2022
$5.2M
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)UH3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2019 to 2022
$4.4M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost ExtensionUH3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2019 to 2022
$4.0M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UH3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D, STOPKA, THOMAS J · 2019 to 2022
$3.9M
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)U24DA048538 · NIDA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., TSUI, JUDITH · 2019 to 2023
$3.7M
Community-based, client-centered prevention homes to address the rural opioid epidemicUH3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2019 to 2022
$2.6M
Learning from the COVID-19 pandemic to improve emergency management planning for harm reduction services in rural OhioUH3DA044822 · NIDA · OHIO STATE UNIVERSITY · PI GO, VIVIAN F., MILLER, WILLIAM C · 2019 to 2022
$2.5M
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern AppalachiaUH3DA044823 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZULE, WILLIAM A · 2019 to 2021
$2.4M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UG3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D · 2017 to 2018
$1.6M
Community-based, client-centered prevention homes to address the rural opioid epidemicUG3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2017 to 2018
$1.4M
Kentucky Communities & Researchers Engaging to Halt the Opioid Epidemic-CARE2HOPEUG3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2017 to 2018
$1.3M
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern AppalachiaUG3DA044823 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZULE, WILLIAM A · 2017 to 2018
$1.2M
NIDA NIH HHS U24 DA048538NIDA NIH HHS UG3 DA044798NIDA NIH HHS UG3DA044798NIDA NIH HHS UG3 DA044822NIDA NIH HHS UG3DA044822NIDA NIH HHS UG3 DA044823NIDA NIH HHS UG3DA044823NIDA NIH HHS UG3 DA044825NIDA NIH HHS UG3DA044825NIDA NIH HHS UG3 DA044826NIDA NIH HHS UG3DA044826NIDA NIH HHS UG3 DA044829NIDA NIH HHS UG3DA044829NIDA NIH HHS UG3 DA044830NIDA NIH HHS UG3DA044830NIDA NIH HHS UG3 DA044831NIDA NIH HHS UG3DA044831NIDA NIH HHS UH3 DA044798NIDA NIH HHS UH3DA044798NIDA NIH HHS UH3 DA044822NIDA NIH HHS UH3DA044822NIDA NIH HHS UH3 DA044823NIDA NIH HHS UH3DA044823NIDA NIH HHS UH3 DA044826NIDA NIH HHS UH3DA044826NIDA NIH HHS UH3 DA044829NIDA NIH HHS UH3DA044829NIDA NIH HHS UH3 DA044830NIDA NIH HHS UH3DA044830NIDA NIH HHS UH3 DA044831NIDA NIH HHS UH3DA044831
6 · The paper itself

Abstract

The Rural Opioid Initiative surveyed 2693 people who inject drugs (PWID) in eight rural U.S. areas in 2018-2020 about self-reported HIV testing in the past 6 months. Correlates of interest included receipt of any drug-related services, incarceration history, and structural barriers to care (e.g., lack of insurance, proximity to syringe service programs [SSP]). Overall, 20% of participants reported receiving an HIV test within the past 6 months. Multivariable generalized estimating equations showed that attending substance use disorder (SUD) treatment (OR 2.11, 95%CI [1.58, 2.82]), having health insurance (OR 1.42, 95%CI [1.01, 2.00]) and recent incarceration (OR 1.49, 95%CI [1.08, 2.04]) were positively associated with HIV testing, while experiencing a resource barrier to healthcare (inability to pay, lack of transportation, inconvenient hours, or lack of child care) had inverse (OR 0.73, 95%CI [0.56, 0.94]) association with HIV testing. We found that the prevalence of HIV testing among rural PWID is low, indicating an unmet need for testing. While SUD treatment or incarceration may increase chances for HIV testing for rural PWID, other avenues for expanding HIV testing, such as SSP, need to be explored.

Indexed as

Drug UsersHIV InfectionsSubstance Abuse, IntravenousCross-Sectional StudiesHIV TestingHumansBarriers to servicesHIV testingPWIDRural

Identifiers

PMID37515742
PMCPMC10823036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.